Prescription medication · Loop Diuretic
ethacrynic acid
Also sold as Edecrin. This medicine treats swelling (edema) caused by heart failure, liver problems like cirrhosis, and kidney disease.
Data updated 2026-05-15
- 520
- FDA reportsRarely reported
- 5
- InteractionsFew interactions
- $1.16
- Generic price (NADAC)
What the data shows
ethacrynic acid (Edecrin) is a prescription Loop Diuretic, among the least-reported drugs the FDA tracks (520 FDA reports), with 5 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
ethacrynic acid (Edecrin) is a prescription Loop Diuretic. This medicine treats swelling (edema) caused by heart failure, liver problems like cirrhosis, and kidney disease.
Ethacrynic acid (Edecrin) is a strong diuretic, also known as a water pill. It helps your body get rid of extra fluid.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$1.16/unit
Generic Available
Yes (6 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
This medicine treats swelling (edema) caused by heart failure, liver problems like cirrhosis, and kidney disease.
Common side effects
Loss of appetite, Feeling unwell, Stomach discomfort or pain
Key warnings
You should not take this medicine if you cannot urinate.
The sections below are summarized in plain English from ethacrynic acid's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Ethacrynic acid helps your kidneys remove extra salt and water from your body. It works in a specific part of the kidney called the loop of Henle. This reduces fluid buildup and lowers blood pressure.
How to Take It
Take Edecrin tablets by mouth. Your doctor will tell you how much to take. Start with the lowest dose needed to gradually lose 1 to 2 pounds per day. You can take it with or after a meal. Your doctor may adjust your dose every few days.
This is a plain-language summary of ethacrynic acid's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.
Pregnancy & Breastfeeding
Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is not known if Edecrin will harm your unborn baby. Talk to your doctor about the risks and benefits of taking this medicine during pregnancy or while breastfeeding.
This is a plain-language summary of ethacrynic acid's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
This is a plain-language summary of ethacrynic acid's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.
Storage
Store in a tightly closed container at room temperature (77°F), but it is ok to be between 59° to 86°F.
Side Effects (from patient reports)
Based on 520 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for ethacrynic acid, by number of reports
- Drug reaction with increased white blood cells and body-wide symptoms
Drug reaction with increased white blood cells and body-wide symptoms
59 reports
- Feeling sick to your stomach
Feeling sick to your stomach
43 reports
- Difficulty breathing
Difficulty breathing
42 reports
- Sudden damage to the kidneys
Sudden damage to the kidneys
33 reports
- Tiredness
Tiredness
32 reports
- Loose, watery stools
Loose, watery stools
31 reports
- Throwing up
Throwing up
31 reports
- Allergic reaction to the medicine
Allergic reaction to the medicine
28 reports
- Weakness
Weakness
25 reports
- Death
Death
24 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for ethacrynic acid each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where ethacrynic acid sits
ethacrynic acid has more FDA adverse-event reports than 3% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is ethacrynic acid; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 520 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 1997–2025.
Total Reports
520
Reports Mentioning Death
64
12.3% of reports — not proof of cause
Hospitalization Reports
212
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 59 |
| 3 | NAUSEA | 43 |
| 4 | DYSPNOEA | 42 |
| 6 | ACUTE KIDNEY INJURY | 33 |
| 7 | FATIGUE | 32 |
| 8 | DIARRHOEA | 31 |
| 9 | VOMITING | 31 |
| 10 | DRUG HYPERSENSITIVITY | 28 |
| 11 | ASTHENIA | 25 |
| 12 | DEATH | 24 |
| 13 | WEIGHT DECREASED | 24 |
| 14 | DIZZINESS | 23 |
| 15 | HEADACHE | 23 |
| 16 | MALAISE | 23 |
| 17 | HYPOTENSION | 21 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
You should not take this medicine if you cannot urinate. If you develop increasing electrolyte imbalance, increased nitrogen in your blood, and/or decreased urination during treatment for severe, worsening kidney disease, stop taking this medicine. If you experience severe, watery diarrhea, stop taking Edecrin and do not take it again. Edecrin can sometimes cause deafness, ringing in the ears, and dizziness.
Known Drug Interactions
Drug Interactions Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity. Read circulars for lithium preparations before use of such concomitant therapy.
Mechanism: Ethacrynic acid makes it harder for the kidneys to remove lithium from the body. This can cause lithium to build up to dangerous levels.
What to do: Avoid taking these two drugs together. If they must be used, your doctor should monitor your lithium levels very closely.
A number of drugs, including ethacrynic acid, have been shown to displace warfarin from plasma protein; a reduction in the usual anticoagulant dosage may be required in patients receiving both drugs.
Mechanism: Ethacrynic acid knocks warfarin off the proteins it usually sticks to in your blood. This leaves more active warfarin in your system, which can increase the risk of bleeding.
What to do: Your doctor may need to reduce your warfarin dose and check your blood clotting time more often.
Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide) – enhanced hypokalemia.
Mechanism: Both drugs cause the body to get rid of potassium through the urine. This can lead to very low potassium levels in your blood.
What to do: Your doctor should check your blood potassium levels often and may suggest a supplement if needed.
Furosemide should not be used concomitantly with ethacrynic acid because of the possibility of ototoxicity.
Mechanism: Using these two medicines together can increase the risk of hearing loss or ear damage.
What to do: Do not take these two medications at the same time.
7.6 Ototoxic Drugs Loop diuretics increase the ototoxic potential of other ototoxic drugs, including aminoglycoside antibiotics and ethacrynic acid.
Mechanism: Both drugs can be harmful to your ears. Taking them together increases the chance of hearing loss or balance problems.
What to do: Use this combination with caution and tell your doctor right away if you notice ringing in your ears or hearing changes.
This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.
Common Questions
Can I take Edecrin if I have kidney problems?
What should I do if I get diarrhea while taking Edecrin?
Can Edecrin affect my hearing?
How quickly will Edecrin start working?
Can I take Edecrin with other diuretics?
What if I am allergic to Edecrin?
Will Edecrin affect my blood sugar?
Can Edecrin cause gout?
Does Edecrin interact with other medications?
How will my doctor monitor me while I am taking Edecrin?
What are the common side effects of ethacrynic acid?
Does ethacrynic acid interact with other medications?
What drug class is ethacrynic acid?
Is ethacrynic acid safe during pregnancy?
Related Medications in Loop Diuretic
Other drugs grouped near ethacrynic acid - same-class peers and common alternatives.
adenosine
Adenocard
Adenosine (Adenocard) is a medicine used to treat certain types of irregular heartbeats.
Compare with ethacrynic acid →
amiodarone
Cordarone, Pacerone
Amiodarone (Pacerone) is a medicine used to treat life-threatening, irregular heartbeats.
Compare with ethacrynic acid →
atropine
AtroPen
Atropine is a medicine that can temporarily block severe effects on your body.
Compare with ethacrynic acid →
bumetanide
Bumex
Bumetanide is a water pill (diuretic).
Compare with ethacrynic acid →
carvedilol
Coreg
Carvedilol is a medicine that lowers blood pressure and helps your heart work better.
Compare with ethacrynic acid →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on ethacrynic acid
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for ethacrynic acid
The FDA label for ethacrynic acid (sold under brand names such as Edecrin) classifies it as a prescription-only medication in the Loop Diuretic class. This medicine treats swelling (edema) caused by heart failure, liver problems like cirrhosis, and kidney disease. Official labeling lists 14 commonly reported side effects, including Loss of appetite, Feeling unwell, Stomach discomfort or pain.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 520 voluntary reports. The database also lists 5 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $1.16.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: August 31, 2020
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages